Biopsies have long been the gold standard diagnostic tool in medicine, a trusted window into the body’s most guarded secrets. For more than a century, the formula has barely changed: take a piece of tissue, place it on a slide, stain it, and rely on a pathologist’s expert eye to decode what’s really happening inside. …
Continue reading “The Evolution and Future of Biopsies: From Cutting Tissue to Decoding Data”
In our last article, we discussed how “Healthy Aging” is emerging as a new, targeted therapeutic area. Among the most surprising candidates showing promise in this field are glucagon-like peptide-1 receptor agonists (GLP-1 RAs) – medications originally developed to target diabetes. Research into GLP-1 RAs has an interesting history that started back in the early …
Continue reading “Could GLP-1 Receptor Agonists Become the First True “Longevity-Enhancing” Drugs?”
In the previous chapters of this series, we revealed how the historic exclusion of women from research, along with long-standing gaps in addressing female-specific health issues continues to have far-reaching consequences for diagnostics, treatment options and outcomes. Decades of underrepresentation within clinical trials, gaps in provider training, the legacy of the WHI 2002 report on …
Continue reading “The Care Gap, Chapter 7 – Charting a Path Forward”
In this second part of Chapter 5, we continue our focus on issues specific to women’s health and discuss gaps in supporting pregnancy from preconception to postpartum care. Maternal Morbidity: Behind the eight ball In the USA, after decades of decline, the number of women who die from complications due to pregnancy and childbirth started …